Intellectual Property

  • July 14, 2026

    Google Faces Another AI Copyright Suit By Publishers

    Book publishers and legal novelist Scott Turow have lodged a copyright infringement suit alleging Google used their works to train its artificial intelligence model Gemini following an earlier suit they launched against Meta.

  • July 14, 2026

    Pharma Cos. Clash In Del. Chancery Over Dental Drug License

    Ventis Pharma Inc. has sued Balanced Pharma Inc. in the Delaware Chancery Court, accusing its licensee of failing to make commercially reasonable efforts to develop and market a licensed dental anesthetic product and seeking a declaration that the companies' exclusive licensing agreement has been terminated.

  • July 14, 2026

    AstraZeneca To Acquire Lung Cancer Drug License For $1.5B

    Multinational pharma giant AstraZeneca said Tuesday that it has agreed to acquire worldwide rights to develop and commercialize a lung cancer drug for as much as $1.5 billion from Chinese pharma company Dizal Pharmaceutical Co. Ltd.

  • July 13, 2026

    Portofino Says Citadel Used Dismissal To Fuel Press Campaign

    Portofino Technologies has accused Citadel Securities of using its decision to drop its trade secrets lawsuit against the Swiss cryptocurrency trading firm as an opportunity to drum up bad press about Portofino, and papering over the fact that an $8 million judgment it won in the dispute is a "pyrrhic victory."

  • July 13, 2026

    Netflix Wins $3M Atty Fees Over 'Objectively Baseless' IP Suit

    A California federal judge granted Netflix Inc. $3 million in attorney fees on Monday, ruling that the plaintiff in a patent suit and his attorney knew that his claims of ownership were "objectively baseless" and worked to conceal a Finnish court's determination that he did not own the patent.

  • July 13, 2026

    Ye Wants New Trial Over 'Donda' Listening Party Infringement

    The artist formerly known as Kanye West is asking a California federal judge for a new trial over infringement of an unlicensed sample, saying the composers of the sampled song were on board until after Ye played it at a 2021 listening party.

  • July 13, 2026

    After Favorable Ruling, Maxell Files New Samsung ITC Suit

    Japan's Maxell Ltd. alleged in a U.S. International Trade Commission suit Friday that South Korea-based Samsung's smartphones and tablets infringe six patents, days after an ITC judge backed Maxell in a separate case and recommended an import ban on infringing Samsung devices.

  • July 13, 2026

    IBM Gets Win On Mainframe Patent Infringement Claims

    A Swiss company infringed IBM patents covering its mainframe software, a Western District of Texas judge found Monday, although he declined for now to give the tech giant a win on the trade secrets component of its case.

  • July 13, 2026

    Judge Newman Won't Reopen High Court Suspension Battle

    Federal Circuit Judge Pauline Newman did not ask the U.S. Supreme Court to reconsider her bid to save a suit against her fellow judges for suspending her from the bench over her refusal to undergo medical tests.

  • July 13, 2026

    AT&T, Verizon, T-Mobile Settle Wireless Patent Suits

    AT&T, Verizon Wireless and T-Mobile have agreed to settle lawsuits accusing them of infringing wireless communications system patents the cellular carriers unsuccessfully tried to invalidate at the Patent Trial and Appeal Board.

  • July 13, 2026

    Toyota Should Be Freed From IP Suit, Judge Says

    A Texas federal judge has recommended allowing Toyota to avoid allegations it infringed a half dozen vehicle infotainment patents, saying the automaker already has a license to the intellectual property.

  • July 13, 2026

    Jury Finds Mass. Engineer Guilty Of Sharing Tech With Iran

    A semiconductor company employee was convicted on Monday of sharing navigation technology with potential military applications with an Iranian business associate in violation of U.S. sanctions.

  • July 13, 2026

    Sony Seeks Atty Fees After 'Bye Bye Bye' Suit Dropped

    Sony Music Holdings Inc. has asked an Atlanta federal judge to order the artist behind NSYNC's "Bye Bye Bye" choreography to pay its attorney fees after he dropped Sony from a copyright infringement suit, saying the case should have never been filed and was prolonged unnecessarily.

  • July 13, 2026

    Software Co.'s Lack Of 'Diligence' Dooms Late TM Suit Update

    A North Carolina federal judge has faulted a software company's "lack of diligence" in submitting proper paperwork to the U.S. Patent and Trademark Office and notifying the court its trademark was canceled as the judge denied the company's request to amend its lawsuit against a European rival.

  • July 13, 2026

    7th Circ. Revives Teva Suit Over Eli Lilly Generic Drug Block

    The Seventh Circuit on Monday revived a breach-of-contract lawsuit against Eli Lilly, ruling that an earlier legal settlement under which Eli Lilly agreed not to block the approval and marketing of Teva Pharmaceuticals' generic version of its osteoporosis drug Forteo didn't necessarily expire when the underlying patents did.

  • July 13, 2026

    Vodka Co. Looks To Block Golf Tour's Use Of 'LIV' Trademark

    A New York distillery has asked a federal judge to scuttle the formerly Saudi-backed golf tour's use of the "LIV" trademark for alcohol sales, arguing that the tour is threatening to diminish its brand.

  • July 13, 2026

    Amazon Settles With AI Worker Who Alleged It Ignored IP Law

    A Los Angeles judge dismissed a lawsuit Monday by an artificial intelligence researcher who alleged the company ignored numerous laws in a frantic attempt to catch up to its artificial intelligence rivals after the parties reached an out-of-court settlement.

  • July 13, 2026

    Fed. Circ. OKs Roku's PTAB Win Axing Ecolink Patent Claims

    The Federal Circuit on Monday upheld a decision from the Patent Trial and Appeal Board invalidating six claims of a "smart" alarm device patent that was challenged by Roku Inc.

  • July 13, 2026

    Fed. Circ. Removes Early Sales Ban In Door Patent Case

    The Federal Circuit on Monday again threw out a preliminary injunction barring sales of insulated doors while patent litigation over them plays out, ruling an Ohio federal judge wrongly found that the patent owner and a licensee were likely to prevail in the case.

  • July 13, 2026

    Catching Up With Delaware's Chancery Court

    The Delaware Chancery Court last week handled disputes involving corporate control, post-closing competition, executive departures, arbitration awards and shareholder litigation.

  • July 13, 2026

    Fed. Circ. Revives Google Fight Against Voice Tech Patent

    The Federal Circuit on Monday gave Google a new chance to invalidate a patent covering a voice-operated internet browsing system, saying the Patent Trial and Appeal Board needs to take another look at the company's challenge.

  • July 10, 2026

    Quince Seeks $1.8M After 'Exceptional' Ugg IP Trial

    "Luxury lookalike" retailer Quince has asked a California federal judge to order Deckers Outdoor Corp. to pay $1.8 million in legal fees and costs in what it called an "exceptional" case after a jury found Deckers' design patent for its Ugg Classic Ultra Mini Boot was invalid.

  • July 10, 2026

    Publisher Draws Injunction After $102M Verdict In Art Case

    A New York federal judge on Friday permanently blocked an art publisher from reproducing works of the late artist Robert Indiana, including his famous stacked "LOVE" imagery, following a more than $102 million verdict against him in a case from the Morgan Art Foundation.

  • July 10, 2026

    Fed. Circ. Judge Calls Patent Case In-Court Demo 'Misleading'

    A Federal Circuit judge chided a company Friday morning for bringing its own specialized oil drilling tool to court to demonstrate to the panel how a device that allegedly infringes its patent works.

  • July 10, 2026

    Meta Secures Toss Of Swedish Soundtrack Co.'s Music IP Suit

    A California federal judge Friday tossed Swedish soundtrack company Epidemic Sound AB's copyright infringement lawsuit that accused Meta of offering its sounds to the social media giant's billions of users without permission, saying Epidemic failed to plausibly allege its sounds were "substantially similar" to those Meta made available.

Expert Analysis

  • Malpractice Claim Assignability Continues To Divide Courts

    Author Photo

    Recent decisions from courts across the country demonstrate how different jurisdictions balance competing policy interests in determining whether legal malpractice claims can be assigned, providing a framework to identify when and how to challenge any attempted assignment, says Christopher Blazejewski at Sherin & Lodgen.

  • Tips For Financial Advisers Facing TRO From Former Firm

    Author Photo

    The Eighth Circuit's recent decision in Choreo v. Lors, overturning a lower court's sweeping injunction after financial advisers moved to a new firm, gives advisers new strategies to fight restraining orders from their old firms, such as focusing on whether the alleged irreparable harm is calculable, say attorneys at Kutak Rock.

  • Learning From A Typical Section 1782 Discovery Case

    Author Photo

    A California federal judge's recent approval of a Section 1782 application, compelling a U.S.-based company to produce materials relevant to a German patent dispute, usefully illustrates the specific steps foreign litigants must undertake before wielding this powerful tool for obtaining evidence unavailable via discovery mechanisms abroad, say attorneys at Fish & Richardson.

  • How To Trademark A Guy In 8 Ways: An IP Strategy Against AI

    Author Photo

    Attempting a novel method of protection against artificial intelligence misuse of his voice and likeness, Matthew McConaughey's recent efforts to register eight trademarks for a series of audio and video clips of himself underscore the importance of extending existing legal frameworks beyond traditional applications, says Summer Todd at Patterson Intellectual Property.

  • Utilizing The ITC To Combat 'Gray Market' IP Infringement

    Author Photo

    As technological developments intensify trademark owners' need to respond swiftly to "gray market" sales of international goods imported into the U.S. without the trademark owner's consent, litigating at the U.S. International Trade Commission offers an underutilized enforcement option, say attorneys at MoFo.

  • Series

    Teaching Logic Makes Me A Better Lawyer

    Author Photo

    Teaching middle and high school students the skills to untangle complicated arguments and identify faulty reasoning has made me reacquaint myself with the defined structure of thought, reminding me why logic should remain foundational in the practice of law, says Tom Barrow at Woods Rogers.

  • From IPR To EPR: The Rapid Rise Of Ex Parte Reexamination

    Author Photo

    With the current administration's dramatic shifts in policy rendering inter partes reviews essentially unavailable for the majority of patents being asserted in litigation, IPR filing rates have plunged, and ex parte reexamination requests have surged to the average rate of IPR petitions in 2024, say attorneys at McKool Smith.

  • Series

    Law School's Missed Lessons: Practicing Resilience

    Author Photo

    Resilience is a skill acquired through daily practices that focus on learning from missteps, recovering quickly without internalizing defeat and moving forward with intention, says Nicholas Meza at Quarles & Brady.

  • Upshot Of 'Skinny Label' Case May Go Beyond Pharma

    Author Photo

    The U.S. Supreme Court's pending review of Hikma v. Amarin, over a drugmaker's "skinny label," carries implications for both generics and brand-name pharmaceutical manufacturers, and could shed light on how inducement doctrine should operate in other regulated industries where products have substantial lawful uses, says Jason Shull at Banner Witcoff.

  • Assessing Factors Behind Biosimilar Uptake And Competition

    Author Photo

    As biosimilar uptake remains uneven and questions linger over whether the Biologics Price Competition and Innovation Act can deliver robust competition between biologics and biosimilars, a case study of Humira and its biosimilars illustrates how many factors, including payor reimbursement and formulary strategy, collectively shape competitive dynamics, say analysts at Analysis Group.

  • How 2 Tech Statutes Are Being Applied To Agentic AI

    Author Photo

    The application of the Computer Fraud and Abuse Act and the California Invasion of Privacy Act to agentic artificial intelligence is still developing, but recent case law, like Amazon's lawsuit against Perplexity in California federal court, provides some initial guidance for companies developing or deploying these technologies, say attorneys at Weil.

  • FTC Focus: Testing Joint Enforcement Over Loyalty Programs

    Author Photo

    The Federal Trade Commission's case against Syngenta can be understood both as a canary for further scrutiny over loyalty-discount practices and a signal of the durability of joint federal-state antitrust enforcement, with key takeaways for practitioners and those subject to regulatory antitrust scrutiny alike, say attorneys at Proskauer.

  • NYC Bar Opinion Warns Attys On Use Of AI Recording Tools

    Author Photo

    Attorneys who use artificial intelligence tools to record, transcribe and summarize conversations with clients should heed the New York City Bar Association’s recent opinion addressing the legal and ethical risks posed by such tools, and follow several best practices to avoid violating the Rules of Professional Conduct, say attorneys at Smith Gambrell.

  • Series

    The Biz Court Digest: Dispatches From Utah's Newest Court

    Author Photo

    While a robust body of law hasn't yet developed since the Utah Business and Chancery Court's founding in October 2024, the number of cases filed there has recently picked up, and its existence illustrates Utah's desire to be top of mind for businesses across the country, says Evan Strassberg at Michael Best.

  • Checking In On Biologics-Related Patent Review Trends

    Author Photo

    Comprehensive analysis of Patent Trial and Appeal Board data since the PTAB's creation indicates that while inter partes review and post-grant review are potent weapons for challenging biologics-related patents, recent policy changes may reduce their effectiveness, say attorneys at Steptoe.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.